(3.227.235.216)
Users online: 2379    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2020, Volume : 13, Issue : 8
First page : ( 3565) Last page : ( 3568)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.00630.7

RP-hplc method development and validation of midazolam: A cyp3a4 probe drug

Sabarathinam Sarvesh, Vijayakumar T M

Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur-603203, Tamil Nadu, India

*Corresponding Author E-mail: vijaypractice@yahoo.com

Online published on 16 September, 2020.

Abstract

An accurate and precise method developed and validated for Midazolam. Midazolam was analyzed by a Reverse phase high-performance liquid chromatography system with PDA detector (Agilent technologies 1220 Infinity II LC). LC solution software was used to record the data. C18- 250mm × 4.6mm and 5μm, using a mobile phase solution of ACN: water (70:30% v/v) mobile phase. Midazolam was detected at retention time 1.627 min using flow rate of 1.0ml/min at 220 nm. At 2–20μg/ml range, calibration was estimated with a regression coefficient of r2 is 0.997. Based on the recovery data, the current method was considered simple and accurate. Limit of Detection (LOD) were 0.17μg/ml and Limit of Quantification (LOQ) was 0.5μg/ml, values was found to be within the limits. This result shows that the method was well validated and quicker, cost-effective for routine analysis of Midazolam.

Top

Keywords

Development, Linearity, RP-HPLC, Validation, Midazolam.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
514,524,778 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.